Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Insulin Receptor Blocking Peptide (AC1324)
Cat.#: ACPP-1324
Specifications
Despition Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1593 Human MED7 Protein (AC1593) 5 µg inquiry ACPP-1306 FGFR2 Blocking Peptide (AC1306) 250 µg inquiry ACPP-1485 Rat VEGF C Protein (152 a.a.) (AC1485) 2 µg inquiry ACPP-1074 Myocilin Blocking Peptide (AC1074) 250 µg inquiry ACPP-1150 Synthetic Nanodisc Human TRPV1 Protein (AC1150) 10 µg inquiry ACPP-1487 Human Pleiotrophin Protein (AC1487) 5 µg inquiry ACPP-1797 Human S100A5 Protein (AC1797) 5 µg inquiry ACPP-1575 Human HMOX1 Protein (AC1575) 10 µg inquiry ACPP-1772 Human CALB2 Protein (AC1772) 5 µg inquiry ACPP-1465 Human CHRNA3 Protein (AC1465) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket